Press Releases

All Releases
View Summary Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects
Dec 4, 2017
PDF 554.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Strengthens Executive Leadership Team
Nov 28, 2017
PDF 548.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
Nov 2, 2017
PDF 372.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference
Nov 1, 2017
PDF 278.9 KB Add to Briefcase
View Summary Ironwood Highlights Breadth of Gout Research to be Presented at the 2017 ACR/ARHP Annual Meeting
Oct 30, 2017
PDF 38.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call
Oct 19, 2017
PDF 279.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017
Oct 16, 2017
PDF 332.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Leadership Change
Sep 6, 2017
PDF 281.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Aug 31, 2017
PDF 14.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces FDA Approval of DUZALLO® (lesinurad and allopurinol) for the Treatment of Hyperuricemia in Patients with Uncontrolled Gout
Aug 21, 2017
PDF 334.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update
Aug 3, 2017
PDF 101.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call
Jul 20, 2017
PDF 12.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease
Jul 20, 2017
PDF 290.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Jun 8, 2017
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Jefferies Healthcare Conference
Jun 1, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference
May 10, 2017
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Presents Data Further Elucidating Linaclotide's Effect on Pain at Digestive Disease Week® 2017
May 9, 2017
PDF 337.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2017 Investor Update
May 8, 2017
PDF 99.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present New Data for Linaclotide, Linaclotide Delayed Release and IW-1701 at Digestive Disease Week® 2017
May 1, 2017
PDF 292.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2017 Investor Update Call
Apr 24, 2017
PDF 13.0 KB Add to Briefcase
Showing 1-20 of 250 Page: 1 2 3 4 5 ... 13  Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.